mProX™ Human SUCNR1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- GPCR Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Rose
Verified Customer
Leopold
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 LysM-Cre Sucnr1fl/fl mice are refractory to prolonged cold-induced browning in scWAT.
Representative pictures of UCP1 immunohistochemistry staining in BAT from two separate experiments, as well as immunoblot quantification of UCP1 protein in BAT (right) and the ratio of UCP1/FAA conducted (middle).
Ref: Keiran, Noelia, et al. "SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity." Nature immunology 20.5 (2019): 581-592.
Pubmed: 30962591
DOI: 10.1038/s41590-019-0372-7
Research Highlights
This study demonstrated that dietary succinate induces tuft and goblet cell hyperplasia via Sucnr1 and the gustducin and Trpm5 chemosensory signaling molecules that are specifically expressed in intestinal tuft cells but not in other types of intestinal epithelial cells.
Lei, Weiwei, et al. "Activation of intestinal tuft cell-expressed Sucnr1 triggers type 2 immunity in the mouse small intestine." Proceedings of the National Academy of Sciences 115.21 (2018): 5552-5557.
Pubmed:
29735652
DOI:
10.1073/pnas.1720758115
SUCNR1 has a great deal of promise as a novel pharmacological target and is presumably a key regulator of fundamental physiology. More specialized pharmacological tools, such as small-molecule modulators, will be a valuable asset in the effort to fully characterize this receptor.
Gilissen, Julie, et al. "Insight into SUCNR1 (GPR91) structure and function." Pharmacology & therapeutics 159 (2016): 56-65.
Pubmed:
26808164
DOI:
10.1016/j.pharmthera.2016.01.008